American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors

D Saslow, PE Castle, JT Cox, DD Davey… - CA: a cancer journal …, 2007 - Wiley Online Library
Abstract The American Cancer Society (ACS) has developed guidelines for the use of the
prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical …

Measurement of subjective phenomena in primary care research: the Visual Analogue Scale.

MD Miller, DG Ferris - Family practice research journal, 1993 - europepmc.org
The visual analogue scale is a technique used to measure subjective phenomena. It is a self-
reporting device consisting of a line of predetermined length that separates extreme …

Advances in prevention of cervical cancer and other human papillomavirus-related diseases

IH Frazer, JT Cox, EJ Mayeaux Jr… - The Pediatric …, 2006 - journals.lww.com
In theory, recognition that a pandemic infection is responsible for more than half a million
cancer cases each year would attract huge media attention, and infection control would …

[HTML][HTML] Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

SM Garland, M Hernandez-Avila… - … England Journal of …, 2007 - Mass Medical Soc
Background A phase 3 trial was conducted to evaluate the efficacy of a prophylactic
quadrivalent vaccine in preventing anogenital diseases associated with human …

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

DM Harper, EL Franco, C Wheeler, DG Ferris… - The lancet, 2004 - thelancet.com
Background Vaccination against the most common oncogenic human papillomavirus (HPV)
types, HPV-16 and HPV-18, could prevent development of up to 70% of cervical cancers …

[HTML][HTML] Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males

AR Giuliano, JM Palefsky, S Goldstone… - … England Journal of …, 2011 - Mass Medical Soc
Background Infection with human papillomavirus (HPV) and diseases caused by HPV are
common in boys and men. We report on the safety of a quadrivalent vaccine (active against …

[HTML][HTML] HPV vaccine against anal HPV infection and anal intraepithelial neoplasia

JM Palefsky, AR Giuliano, S Goldstone… - … England Journal of …, 2011 - Mass Medical Soc
Background The rate of anal cancer is increasing among both women and men, particularly
men who have sex with men. Caused by infection with human papillomavirus (HPV) …

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a …

EA Joura, S Leodolter, M Hernandez-Avila… - The Lancet, 2007 - thelancet.com
Background Vulval and vaginal cancers among younger women are often related to
infection with human papillomavirus (HPV). These cancers are preceded by high-grade …

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine …

DR Brown, SK Kjaer, K Sigurdsson… - The Journal of …, 2009 - academic.oup.com
Abstract Background Human papillomavirus (HPV)–6/11/16/18 vaccine reduces the risk of
HPV-6/11/16/18–related cervical intraepithelial neoplasia (CIN) 1–3 or adenocarcinoma in …

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women

N Muñoz, SK Kjaer, K Sigurdsson… - Journal of the …, 2010 - academic.oup.com
Background The impact of the prophylactic vaccine against human papillomavirus (HPV)
types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was …